Citizens Financial Group Inc. RI Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Citizens Financial Group Inc. RI lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,036 shares of the healthcare conglomerate's stock after purchasing an additional 2,600 shares during the quarter. Citizens Financial Group Inc. RI's holdings in UnitedHealth Group were worth $25,162,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Tealwood Asset Management Inc. bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $2,905,000. Asset Planning Services Inc. LA ADV raised its position in UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate's stock valued at $7,288,000 after purchasing an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate's stock valued at $14,603,000 after purchasing an additional 3,006 shares during the period. Americana Partners LLC grew its stake in UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate's stock valued at $11,914,000 after purchasing an additional 1,984 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. boosted its stake in UnitedHealth Group by 14.8% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate's stock valued at $5,072,000 after acquiring an additional 1,283 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on UNH shares. Truist Financial reissued a "buy" rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 17th. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald raised their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 16th. Finally, KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an "overweight" rating and a $675.00 target price on the stock. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $615.53.

UnitedHealth Group Stock Down 0.2 %

Shares of UnitedHealth Group stock traded down $1.15 during trading on Thursday, reaching $599.35. The stock had a trading volume of 968,367 shares, compared to its average volume of 3,867,395. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a fifty day moving average price of $582.52 and a two-hundred day moving average price of $551.60. The company has a market capitalization of $551.57 billion, a price-to-earnings ratio of 39.12, a P/E/G ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.56 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.40%. UnitedHealth Group's payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.